首页> 外国专利> THE USE OF EMIP AS CANCER THERAPEUTICS IN COMBINATION WITH ELECTRON BEAM IRRADIATION OR ADJUVANT TREATMENT

THE USE OF EMIP AS CANCER THERAPEUTICS IN COMBINATION WITH ELECTRON BEAM IRRADIATION OR ADJUVANT TREATMENT

机译:EMIP作为癌症治疗剂与电子束辐照或辅助治疗结合使用

摘要

Satisfactory effects have not always been attained by immunotherapy havingbeen tried, and reliance upon direct attack on cells by anticancer agents,radiation, etc. has been inevitable. It is intended to provide a therapeuticmethod that ensures less side effects but higher efficacy than in conventionaltherapeutic methods through enhancing of immune strength inherently had byliving organism. There is provided an immunopotentiating agent comprisingMIP~1.alpha. or its functional derivative as an active ingredient.
机译:免疫疗法并非总能获得令人满意的效果。经过尝试,并依靠抗癌药对细胞的直接攻击,辐射等已不可避免。旨在提供治疗方法与传统方法相比,可确保更少的副作用,但更高的功效通过增强免疫力固有的治疗方法生物体。提供了一种免疫增强剂,其包含MIP〜1.alpha。或其功能衍生物作为有效成分。

著录项

  • 公开/公告号CA2596232A1

    专利类型

  • 公开/公告日2006-08-03

    原文格式PDF

  • 申请/专利权人 EFFECTOR CELL INSTITUTE;

    申请/专利号CA20052596232

  • 发明设计人 KANEGASAKI SHIRO;TAMATANI TAKUYA;

    申请日2005-12-20

  • 分类号A61K38/19;A61P35;A61P35/04;A61P37/04;A61P37/08;

  • 国家 CA

  • 入库时间 2022-08-21 21:34:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号